Okayama University Scientific Achievement Repositorymetadata only
Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation
bile acids, multiple sclerosis, database analysis, drug repositioning, experimental autoimmune encephalomyelitis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 223136
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.